Chief Strategy & Commercial Officer
Pending…
Pending…
Pending…
Leading is an accomplished Chief Executive Officer with 25 years of global experience as an entrepreneur and executive leader. Throughout his career, he has demonstrated exceptional ability in founding and developing successful businesses, holding pivotal roles including Founder, Director of Marketing, CEO, President, and Board Member across diverse industries such as medical devices, agriculture, media,…
Pending…
Fluorescent Lateral Flow Testing (FLFT) for Early Cancer Detection Our research team has developed a next‑generation fluorescent lateral flow test (FLFT) to power our ultra‑sensitive rapid cancer detection platform. FLFT technology builds on traditional lateral flow assays but replaces colored particles with fluorescent labels, dramatically increasing sensitivity and enabling true quantitative measurement. Why FLFT Matters…
A distinguished member of a Scientific Advisory Council, which has made significant contributions to cancer immunotherapy, particularly in ovarian cancer. His research focuses on identifying tumor antigens and developing immunotherapeutic strategies, including vaccines and engineered T cells, to enhance the immune system’s ability to combat cancer.